China SXT Pharmaceuticals (SXTC) Other Working Capital Changes: 2018-2025
- China SXT Pharmaceuticals' Other Working Capital Changes rose 120.95% to $65,057 in Q3 2025 from the same period last year, while for Sep 2025 it was $887, marking a year-over-year increase of 100.03%. This contributed to the annual value of $223,477 for FY2025, which is 256.09% up from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Other Working Capital Changes of $65,057 as of Q3 2025, which was up 10.97% from $58,627 recorded in Q1 2025.
- In the past 5 years, China SXT Pharmaceuticals' Other Working Capital Changes registered a high of $187,665 during Q1 2024, and its lowest value of -$310,462 during Q3 2024.
- In the last 2 years, China SXT Pharmaceuticals' Other Working Capital Changes had a median value of $61,842 in 2025 and averaged $221.75.
- The largest annual percentage gain for China SXT Pharmaceuticals' Other Working Capital Changes in the last 5 years was 120.95% (2025), contrasted with its biggest fall of 68.76% (2025).
- Over the past 2 years, China SXT Pharmaceuticals' Other Working Capital Changes (Quarterly) stood at -$310,462 in 2024, then surged by 120.95% to $65,057 in 2025.
- Its Other Working Capital Changes stands at $65,057 for Q3 2025, versus $58,627 for Q1 2025 and -$310,462 for Q3 2024.
